Yeast as a biosensor of detoxification: a tool for identifying new compounds that revert multidrug resistance

Carmen Martín-Cordero1, Angeles Sanchez-Pico, Antonio J Leon-Gonzalez

  • 1Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide-Consejo Superior de Investigaciones Cientificas, Junta de Andalucia Ctra. Utrera Km1 41013 Sevilla, Spain. rroddag@upo.es

Current Drug Targets
|April 26, 2013
PubMed

Insights

Multidrug resistance (MDR) in cancer is a major challenge. Researchers propose using fission yeast as a cost-efficient biosensor to screen for new compounds that can inhibit ATP-binding cassette (ABC) transporters, potentially overcoming chemotherapy resistance.

Area of Science:

  • Cancer Biology
  • Molecular Pharmacology
  • Microbiology

Background:

  • Tumor progression involves genetic changes leading to increased malignancy, including chemotherapy resistance.
  • ATP-binding cassette (ABC) transporters confer multidrug resistance (MDR) by extruding anticancer drugs from cells.
  • Existing strategies to inhibit ABC transporters have limited clinical success, necessitating novel approaches.

Purpose of the Study:

  • To introduce a novel, cost-efficient biosensor system for identifying inhibitors of ABC transporters.
  • To leverage fission yeast, Schizosaccharomyces pombe, as a tool for screening natural compounds and chemical libraries.
  • To discover molecules capable of reverting the multidrug resistant phenotype.

Main Methods:

  • Utilizing Schizosaccharomyces pombe as a detoxification biosensor.
  • Screening natural compounds and chemical libraries for MDR-reverting activity.
  • Employing established fission yeast genetic, biochemical, and cell biological analysis tools.

Main Results:

  • Demonstrated the potential of fission yeast as a biosensor for ABC transporter activity.
  • Identified a strategy for cost-efficient screening of potential MDR reversal agents.
  • Facilitated the identification of novel drug targets within the ABC transporter family.

Conclusions:

  • Fission yeast offers a powerful and economical platform for discovering new ABC transporter inhibitors.
  • This approach can accelerate the development of compounds to combat multidrug resistance in cancer therapy.
  • Combining identified inhibitors with chemotherapy may improve treatment outcomes for multidrug-resistant tumors.

Related Concept Videos

Microbial Biosensors01:17

Microbial Biosensors

Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...